BG105207A - Фармацевтичен състав с антитуморна активност на базата на карбоплатин - Google Patents

Фармацевтичен състав с антитуморна активност на базата на карбоплатин

Info

Publication number
BG105207A
BG105207A BG105207A BG10520701A BG105207A BG 105207 A BG105207 A BG 105207A BG 105207 A BG105207 A BG 105207A BG 10520701 A BG10520701 A BG 10520701A BG 105207 A BG105207 A BG 105207A
Authority
BG
Bulgaria
Prior art keywords
carboplatin
pharmaceutical composition
antitumour activity
basis
weight
Prior art date
Application number
BG105207A
Other languages
English (en)
Inventor
Vladimir Kysilka
Libuse LOUKALOVA
Miroslav MA.LECEK
Ronald Gust
Original Assignee
Pliva-Lachema, A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva-Lachema, A.S. filed Critical Pliva-Lachema, A.S.
Publication of BG105207A publication Critical patent/BG105207A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0091—Complexes with metal-heteroatom-bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Фармацевтичният състав включва воден разтвор на карбоплатина със съдържание на карбоплатина от 1 до20 mg/ml. Той съдържа непосредствено след получаването му 1,1-циклобутандикарбонова киселина и/или нейна сол в количество, по-малко от 0,1% тегл. по отношение на теглото на присъстващата карбоплатина.
BG105207A 1998-08-14 2001-01-31 Фармацевтичен състав с антитуморна активност на базата на карбоплатин BG105207A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ19982588A CZ292170B6 (cs) 1998-08-14 1998-08-14 Farmaceutická kompozice s protinádorovým účinkem na bázi carboplatiny
PCT/CZ1999/000028 WO2000009097A2 (en) 1998-08-14 1999-08-10 Pharmaceutical composition with antitumor activity on the basis of carboplatin

Publications (1)

Publication Number Publication Date
BG105207A true BG105207A (bg) 2001-07-31

Family

ID=5465233

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105207A BG105207A (bg) 1998-08-14 2001-01-31 Фармацевтичен състав с антитуморна активност на базата на карбоплатин

Country Status (17)

Country Link
US (1) US6589988B1 (bg)
EP (1) EP1107750B1 (bg)
AT (1) ATE281832T1 (bg)
AU (1) AU5024599A (bg)
BG (1) BG105207A (bg)
CZ (1) CZ292170B6 (bg)
DE (1) DE69921832T2 (bg)
ES (1) ES2229737T3 (bg)
HR (1) HRP20010110B1 (bg)
HU (1) HUP0104304A3 (bg)
NO (1) NO20010507D0 (bg)
PL (1) PL346363A1 (bg)
PT (1) PT1107750E (bg)
RU (1) RU2188640C1 (bg)
SK (1) SK284711B6 (bg)
UA (1) UA73281C2 (bg)
WO (1) WO2000009097A2 (bg)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2267255T3 (es) 1998-04-03 2007-03-01 Ajinomoto Co., Inc. Agentes antitumorales.
AU2005329764B2 (en) * 2005-03-28 2010-08-12 Dabur Pharma Ltd. Stable pharmaceutical compositions of platinum (II) antitumour agents
KR101127159B1 (ko) * 2009-11-02 2012-03-20 한국생명공학연구원 식물병원성 그람음성 세균의 분비체계를 저해하는 카보프라틴 화합물을 유효성분으로 함유하는 식물병 방제제
WO2020044311A1 (en) * 2018-08-31 2020-03-05 Sun Pharmaceutical Industries Limited Parenteral dosage form of carboplatin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS269719B1 (en) * 1986-12-29 1990-05-14 Kiss Frantisek Platinum cytostatic
JPH01146826A (ja) * 1987-12-03 1989-06-08 Nippon Kayaku Co Ltd 白金化合物の凍結乾燥製剤
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
AU5878294A (en) * 1994-02-07 1995-08-21 Kiss Laboratories S.R.O. Anti-tumour medical preparation on the basis of carboplatin and the method of its production

Also Published As

Publication number Publication date
AU5024599A (en) 2000-03-06
UA73281C2 (en) 2005-07-15
HRP20010110B1 (en) 2005-10-31
US6589988B1 (en) 2003-07-08
EP1107750A2 (en) 2001-06-20
CZ258898A3 (cs) 2000-02-16
NO20010507L (no) 2001-01-30
HUP0104304A3 (en) 2004-04-28
DE69921832D1 (de) 2004-12-16
DE69921832T2 (de) 2005-11-03
HRP20010110A2 (en) 2002-02-28
PL346363A1 (en) 2002-02-11
CZ292170B6 (cs) 2003-08-13
WO2000009097A2 (en) 2000-02-24
HUP0104304A2 (hu) 2002-03-28
RU2188640C1 (ru) 2002-09-10
SK2092001A3 (en) 2001-07-10
SK284711B6 (sk) 2005-09-08
EP1107750B1 (en) 2004-11-10
ES2229737T3 (es) 2005-04-16
NO20010507D0 (no) 2001-01-30
WO2000009097A3 (en) 2000-05-18
ATE281832T1 (de) 2004-11-15
PT1107750E (pt) 2005-02-28

Similar Documents

Publication Publication Date Title
DE60021541D1 (de) Herstellung von hochloeslichen und stabilen mineralstoffergaenzungen
AU685126B2 (en) Stabilized solution of platinum (II) antitumor agents
IL138723A (en) Composition containing cisplatin and stilbene for treatment of tumors
DE69011766D1 (de) Wässerige Arzneisuspension für im wesentlichen wasserunlösliche Arzneiwirkstoffe.
US20070270591A1 (en) Iron (II) amino acid chelates with reducing agents attached thereto
CA2472386A1 (en) Cigarette and cigarette filter containing a basic amino acid or a basic amino acid salt
BG105207A (bg) Фармацевтичен състав с антитуморна активност на базата на карбоплатин
EP1254658A4 (en) MEDICINES
JP4072668B2 (ja) 水質改良剤
Ragan The bioavailability of iron, lead and cadmium via gastrointestinal absorption: a review
ES8700054A1 (es) Procedimiento de obtencion de germicidas a base de acidos clorhidrico y fosforico.
RU2001104352A (ru) Фармацевтическая композиция с противоопухолевой активностью на основе карбоплатина
US20030175202A1 (en) Table salt, table sugar, and table vinegar formulations with nitrite scavengers
JP2006321776A (ja) アミノ酸を配位して成る金属錯体である抗菌防カビ剤とその二次製品
MXPA01007210A (es) Agente para el tratamiento de enfermedad de parkinson que comprende un agente que mejora la funcion del astrocito como ingrediente activo.
SG146690A1 (en) Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient
CA2534259A1 (en) Glycyrrhizin high-concentration preparation
EP0236822B1 (en) Stable injectable pharmaceutical formulation for 1,4-dihydroxy-5,8-bis((2-(hydroxyethylamino)-ethyl)amino)anthraquinone, dihydrochloride
MXPA03009765A (es) Utilizacion de galantamina para el tratamiento de patologias del sistema nervioso central originadas por intoxicaciones con sustancias psicotropicas.
JP3824604B2 (ja) 抗酸化作用を有する亜鉛含有物
JP5915013B2 (ja) 内服液剤
GR1004016B (el) Αναβραζοντα δισκια, που περιεχουν ως δραστικο συστατικο συμπλοκες ενωσεις σιδηρου, για την θεραπεια των σιδηροπενικων αναιμιων
JPH0475168B2 (bg)
Lee Cadmium, mercury, and lead—the heavy metal gang
KR20140025369A (ko) 히알루론산 또는 히알루론산염을 포함하는 수용액